- Home
- AFBI vs ADCT Comparison
AFBI vs ADCT Comparison
Compare AFBI & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFBI
- ADCT
- Stock Information
- Founded
- AFBI 1928
- ADCT 2011
- Country
- AFBI United States
- ADCT Switzerland
- Employees
- AFBI N/A
- ADCT N/A
- Industry
- AFBI Major Banks
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- AFBI Finance
- ADCT Health Care
- Exchange
- AFBI Nasdaq
- ADCT Nasdaq
- Market Cap
- AFBI 111.8M
- ADCT 131.8M
- IPO Year
- AFBI N/A
- ADCT 2020
- Fundamental
- Price
- AFBI $18.40
- ADCT $1.21
- Analyst Decision
- AFBI
- ADCT Strong Buy
- Analyst Count
- AFBI 0
- ADCT 5
- Target Price
- AFBI N/A
- ADCT $7.75
- AVG Volume (30 Days)
- AFBI 15.1K
- ADCT 373.9K
- Earning Date
- AFBI 04-29-2025
- ADCT 05-05-2025
- Dividend Yield
- AFBI 8.11%
- ADCT N/A
- EPS Growth
- AFBI N/A
- ADCT N/A
- EPS
- AFBI 0.83
- ADCT N/A
- Revenue
- AFBI $30,608,000.00
- ADCT $70,837,000.00
- Revenue This Year
- AFBI N/A
- ADCT $6.82
- Revenue Next Year
- AFBI N/A
- ADCT $18.56
- P/E Ratio
- AFBI $22.17
- ADCT N/A
- Revenue Growth
- AFBI 3.04
- ADCT 1.84
- 52 Week Low
- AFBI $16.50
- ADCT $1.05
- 52 Week High
- AFBI $22.50
- ADCT $5.17
- Technical
- Relative Strength Index (RSI)
- AFBI 58.85
- ADCT 39.36
- Support Level
- AFBI $17.00
- ADCT $1.13
- Resistance Level
- AFBI $18.21
- ADCT $1.25
- Average True Range (ATR)
- AFBI 0.43
- ADCT 0.11
- MACD
- AFBI 0.11
- ADCT 0.00
- Stochastic Oscillator
- AFBI 83.33
- ADCT 39.51
About AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.